Advertisement
U.S. markets closed

G1 Therapeutics Inc (G1H.BE)

Berlin - Berlin Delayed Price. Currency in EUR
4.0400-0.0700 (-1.70%)
At close: 08:30PM CET
Advertisement
Show:
Annual
Upgrade to begin using 40 years of financial statements and get so much more.

Income Statement

All numbers in thousands
Upgrade to begin using 40 years of financial statements and get so much more.
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
77,888
82,511
51,301
31,476
45,285
Cost of Revenue
6,931
7,195
3,748
2,016
0
Gross Profit
70,957
75,316
47,553
29,460
45,285
Operating Expense
132,442
114,843
183,731
171,917
141,761
Operating Income
-61,485
-39,527
-136,178
-142,457
-96,476
Net Non Operating Interest Income Expense
-8,488
-7,565
-9,684
-4,624
-826
Other Income Expense
1,929
2,240
3
-346
-542
Pretax Income
-68,044
-44,852
-145,859
-147,427
-97,844
Tax Provision
2,694
3,115
1,700
925
1,410
Net Income Common Stockholders
-70,738
-47,967
-147,559
-148,352
-99,254
Diluted NI Available to Com Stockholders
-70,738
-47,967
-147,559
-148,352
-99,254
Basic EPS
-1.43
-
-3.38
-3.54
-2.62
Diluted EPS
-1.43
-
-3.38
-3.54
-2.62
Basic Average Shares
50,351
-
43,626
41,943
37,878
Diluted Average Shares
50,351
-
43,626
41,943
37,878
Total Operating Income as Reported
-61,485
-39,527
-136,178
-142,457
-96,476
Total Expenses
139,373
122,038
187,479
173,933
141,761
Net Income from Continuing & Discontinued Operation
-70,738
-47,967
-147,559
-148,352
-99,254
Normalized Income
-70,738
-47,967
-147,559
-148,352
-99,254
Interest Income
2,422
2,473
748
43
952
Interest Expense
10,910
10,038
10,432
4,667
1,778
Net Interest Income
-8,488
-7,565
-9,684
-4,624
-826
EBIT
-57,134
-34,814
-135,427
-142,760
-96,066
EBITDA
-56,608
-34,301
-134,897
-142,291
-95,484
Reconciled Cost of Revenue
6,931
7,195
3,748
2,016
0
Reconciled Depreciation
526
513
530
469
582
Net Income from Continuing Operation Net Minority Interest
-70,738
-47,967
-147,559
-148,352
-99,254
Normalized EBITDA
-56,608
-34,301
-134,897
-142,291
-95,484
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0